Histamine-induced Vasodilatation in the Human Forearm Vasculature

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2013 Mar 16

PMID 23488545

Citations 5

Authors

Euan A Sandilands

Jane Crowe

Hayley Cuthbert

Paul J Jenkins

Neil R Johnston

Michael Eddleston

D Nicholas Bateman

David J Webb

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the mechanism of action of intra-arterial histamine in the human forearm vasculature.

Methods: Three studies were conducted to assess changes in forearm blood flow (FBF) using venous occlusion plethysmography in response to intra-brachial histamine. First, the dose-response was investigated by assessing FBF throughout a dose-escalating histamine infusion. Next, histamine was infused at a constant dose to assess acute tolerance. Finally, a four way, double-blind, randomized, placebo-controlled crossover study was conducted to assess FBF response to histamine in the presence of H1 - and H2 -receptor antagonists. Flare and itch were assessed in all studies.

Results: Histamine caused a dose-dependent increase in FBF, greatest with the highest dose (30 nmol min(-1) ) infused [mean (SEM) infused arm vs. control: 26.8 (5.3) vs. 2.6 ml min(-1) 100 ml(-1) ; P < 0.0001]. Dose-dependent flare and itch were demonstrated. Acute tolerance was not observed, with an increased FBF persisting throughout the infusion period. H2 -receptor antagonism significantly reduced FBF (mean (95% CI) difference from placebo at 30 nmol min(-1) histamine: -11.9 ml min(-1) 100 ml(-1) (-4.0, -19.8), P < 0.0001) and flare (mean (95% CI) difference from placebo: -403.7 cm(2) (-231.4, 576.0), P < 0.0001). No reduction in FBF or flare was observed in response to the H1 -receptor antagonist. Itch was unaffected by the treatments. Histamine did not stimulate vascular release of tissue plasminogen activator or von Willebrand factor.

Conclusion: Histamine causes dose-dependent vasodilatation, flare and itch in the human forearm. H2 -receptors are important in this process. Our results support further exploration of combined H1 - and H2 -receptor antagonist therapy in acute allergic syndromes.

Citing Articles

Histamine H-receptor antagonism improves conduit artery endothelial function and reduces plasma aldosterone level without lowering arterial blood pressure in angiotensin II-hypertensive mice.

Assersen K, Jensen B, Enggaard C, Vanhoutte P, Hansen P Pflugers Arch. 2024; 476(3):307-321.

PMID: 38279994 PMC: 10847227. DOI: 10.1007/s00424-024-02909-0.

Ipsilateral somatic nerves mediate histamine-induced vasosensory reflex responses involving perivascular afferents in rat models.

Revand R, Singh S Sci Rep. 2021; 11(1):14648.

PMID: 34282171 PMC: 8290047. DOI: 10.1038/s41598-021-94110-x.

Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing.

Wilkinson D, Rodriguez-Blanco G, Dunn W, Phillips B, Williams J, Greenhaff P Aging (Albany NY). 2020; 12(13):12517-12533.

PMID: 32580166 PMC: 7377844. DOI: 10.18632/aging.103513.

Effect of histamine-receptor antagonism on leg blood flow during exercise.

Ely M, Ratchford S, LA Salle D, Trinity J, Wray D, Halliwill J J Appl Physiol (1985). 2020; 128(6):1626-1634.

PMID: 32407239 PMC: 7311692. DOI: 10.1152/japplphysiol.00689.2019.

Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.

Park E, Lee E, Shin K, Kim H Rheumatol Int. 2019; 40(5):791-798.

PMID: 31598752 DOI: 10.1007/s00296-019-04456-9.

References

Pelc L, CHRISTENSEN C, Gross G, Warltier D . Direct cardiac actions of the H2 receptor agonists, impromidine and dimaprit. Eur J Pharmacol. 1985; 107(3):379-84. DOI: 10.1016/0014-2999(85)90266-3. View

Klocking H, Markwardt F . Pharmacological stimulation of t-PA release. Pharmazie. 1994; 49(4):227-30. View

Akdis C, Blaser K . Histamine in the immune regulation of allergic inflammation. J Allergy Clin Immunol. 2003; 112(1):15-22. DOI: 10.1067/mai.2003.1585. View

Simons F . Advances in H1-antihistamines. N Engl J Med. 2004; 351(21):2203-17. DOI: 10.1056/NEJMra033121. View

Flynn S, Owen D . Histamine receptors in peripheral vascular beds in the cat. Br J Pharmacol. 1975; 55(2):181-8. PMC: 1666792. DOI: 10.1111/j.1476-5381.1975.tb07627.x. View

Jilma B, Pernerstorfer T, Dirnberger E, Stohlawetz P, Schmetterer L, Singer E . Effects of histamine and nitric oxide synthase inhibition on plasma levels of von Willebrand factor antigen. J Lab Clin Med. 1998; 131(2):151-6. DOI: 10.1016/s0022-2143(98)90157-3. View

Toda N . Mechanism underlying responses to histamine of isolated monkey and human cerebral arteries. Am J Physiol. 1990; 258(2 Pt 2):H311-7. DOI: 10.1152/ajpheart.1990.258.2.H311. View

Wilkinson I, Webb D . Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications. Br J Clin Pharmacol. 2001; 52(6):631-46. PMC: 2014568. DOI: 10.1046/j.0306-5251.2001.01495.x. View

Smith D, Gilbert M, Owen W . Tissue plasminogen activator release in vivo in response to vasoactive agents. Blood. 1985; 66(4):835-9. View

10.

Spector S, Nicklas R, Chapman J, Bernstein I, Berger W, Blessing-Moore J . Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol. 2003; 91(2):105-14. DOI: 10.1016/s1081-1206(10)62160-6. View

11.

Sampson H, Munoz-Furlong A, Campbell R, Adkinson Jr N, Bock S, Branum A . Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117(2):391-7. DOI: 10.1016/j.jaci.2005.12.1303. View

12.

Felix S, Baumann G, Niemczyk M, Hashemi T, Ochsenfeld G, Ahmad Z . Effects of histamine H1- and H2-receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs. Agents Actions. 1991; 32(3-4):245-52. DOI: 10.1007/BF01980881. View

13.

McCord J, Beasley J, Halliwill J . H2-receptor-mediated vasodilation contributes to postexercise hypotension. J Appl Physiol (1985). 2005; 100(1):67-75. DOI: 10.1152/japplphysiol.00959.2005. View

14.

Bateman D, Woodhouse K, Rawlins M . Adverse reactions to N-acetylcysteine. Hum Toxicol. 1984; 3(5):393-8. DOI: 10.1177/096032718400300504. View

15.

MacGlashan Jr D . Histamine: A mediator of inflammation. J Allergy Clin Immunol. 2003; 112(4 Suppl):S53-9. DOI: 10.1016/s0091-6749(03)01877-3. View

16.

Knop M, Aareskjold E, Bode G, Gerke V . Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells. EMBO J. 2004; 23(15):2982-92. PMC: 514934. DOI: 10.1038/sj.emboj.7600319. View

17.

Spitaler M, Hammer A, Malli R, Graier W . Functional analysis of histamine receptor subtypes involved in endothelium-mediated relaxation of the human uterine artery. Clin Exp Pharmacol Physiol. 2002; 29(8):711-6. DOI: 10.1046/j.1440-1681.2002.03704.x. View

18.

Grossmann M, Jamieson M, Kirch W . Histamine response and local cooling in the human skin: involvement of H1- and H2-receptors. Br J Clin Pharmacol. 1999; 48(2):216-22. PMC: 2014297. DOI: 10.1046/j.1365-2125.1999.00994.x. View

19.

Duff F, Greenfield A, SHEPHERD J, Thompson I . A quantitative study of the response to acetylcholine and histamine of the blood vessels of the human hand and forearm. J Physiol. 1953; 120(1-2):160-70. PMC: 1366029. DOI: 10.1113/jphysiol.1953.sp004883. View

20.

Lin R, Curry A, Pesola G, Knight R, Lee H, Bakalchuk L . Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000; 36(5):462-8. DOI: 10.1067/mem.2000.109445. View